[Hypofibrinolysis in acute myocardial infarction (author's transl)].
D001157:Arterial Occlusive Diseases / Q000097:blood; D001778:Blood Coagulation Disorders / Q000150:complications / Q000188:drug therapy; D005032:Ethylestrenol / Q000627:therapeutic use; D005260:Female; D005342:Fibrinolysis / Q000187:drug effects; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006801:Humans; D006854:Hydrocortisone / Q000494:pharmacology; D066298:In Vitro Techniques; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000097:blood* / Q000150:complications; D010629:Phenformin / Q000627:therapeutic use; D010958:Plasminogen / Q000037:antagonists & inhibitors; D012712:Serum Globulins; D012770:Shock, Cardiogenic / Q000097:blood; D012995:Solubility; D014568:Urokinase-Type Plasminogen Activator
D005343:Fibrinolytic Agents; D012712:Serum Globulins; D010958:Plasminogen; D005032:Ethylestrenol; D010629:Phenformin; D014568:Urokinase-Type Plasminogen Activator; D006854:Hydrocortisone
Hypofibrinolyse beim akuten Myokardinfarkt